Round Table (July 2018)

Our Round Table … is a free monthly webcast that celebrated its 8th anniversary on 7/31/2018.  The concept is simple. Contributors share their best current actionable ideas. Rinse. Repeat. Beat the market. The rate of return for the tracking portfolio (since inception) is 18.2% — topping the Wilshire 5000 by 5.5 percentage points.  The monthly sessions are sponsored by the NAIC Mid-Michigan chapter and Manifest Investing and stock selections/analysis and portfolio stewardship is demonstrated by a number of community participants who have successful stock selection experience and superior performance.

Round Table (July 2018)

The rate of return for the Round Table tracking portfolio stands at 18.2% over the last 8.0 years.

Our July Round Table celebrated our 8th anniversary. It all started with, “Sure … a monthly demonstration of WHAT WE DO would be great … but NO COSTUMES!” — Ken ‘Party Wrecker’ Kavula.  (July 2010)

So no costumes. Occasional hats.

Frequent solid ideas for further study.


Stocks featured during the July session included Cognizant Technology (CTSH) — our most frequently selected stock over the trailing eight years, Coherent (COHR), Ionis Pharma (IONS) and Skechers (SKX).  The audience selected Coherent (COHR).

The slides used during the session are available on request via Mark Robertson (

The video archive is available via YouTube at Round Table — July 2018 If you’d like to be notified whenever videos are uploaded to this channel, subscribe using the button on the page.

Green Room, References Mentioned …

IPG Photonics (IPGP) took quite a hit in trading on Tuesday with the price dropping approximately 26% during the day. See Why IPG Is Falling Hard (Brian Feroldi, Motley Fool) for more information on the situation. The drop would have been enough to dislodge IPGP as the best performing stock from 2016 if Tuesday’s price action were included. We noted that Mark’s selection of Mercadolibre (MELI) would be the new leader for active holdings from 2016.

Signature Bank (SBNY) appeared at the top of the “Closest to 52-Week Low” screen used during the session. Investors are reminded that Eddy Elfenbein of Crossing Wall Street follows SBNY fairly closely as a component of his current Buy List and a number of play-by-play commentaries can be found there. Go to the site and search by ticker (SBNY) if you’re interested in a plethora of features regarding Signature Bank.

Attophysics defined.

One of the books mentioned during the session was Factfulness by Hans Rosling. I’m sure that we’ll be talking more about this in coming weeks and months. For more on this, check out the Forum Post by Sunil Veluvali

The Basics of Tariffs and Trade Barriers (Investopedia)

Links to Challenge Stock Audits:

None of the challenge stocks were sold but we dialed up vigilance on Cambrex (CBM) if the price continues to run in the absence of a robust increase in fundamental expectations.

The tracking portfolio (dashboard) can be found at



Round Table (June 2016)

Our monthly webcast featuring some actionable stock ideas and exploration of some portfolio design & management concepts is tonight, June 28, at 8:30 PM ET.  The following are some of the likely stocks for discussion and some screening results to generate some ideas …

Stocks Likely To Be Discussed

  • Mesa Labs (MLAB)
  • Robert Half (RHI)
  • Biogen (BIIB)


The session starts at 8:30 PM ET. We commonly “open the doors” to the Green Room at approximately 8:15 PM ET for open discussion and socializing. All are welcome. Register via:

Some Screening Results

This daily update lists the tickers of the stocks that became 5-star investments, according to Morningstar, as of the last market close. A stock is awarded 5 stars when its price hits what Morningstar deems is a “Consider Buying” level.

As is often the case, 2-3 horrific days in the stock market leads to a more extensive list. (A typical day has 1-3 entries)

Tracking Dashboard

We’ll follow $100 into each one of these ideas via:

Ivory Screen Stock Search (6/28/2016)

Based on MANIFEST Ranking greater than 99.44 … the MANIFEST Rank is an equally-weighted index based on (1) total return forecast and (2) quality ranking. It represents the top half of the top percentile of current study opportunities.

Ivory screen 20160628

Look Out Below: MYL, NVO & RHI

Lookout Below

During the weekly update, the following stocks were flagged based on a decline from RSI greater than 70 (potentially overbought) to less than 70. Reminder: We use a long-term chart (monthly) for this analysis.

All of these companies should be subjected to an assertive portfolio-centered selling analysis.

  • Mylan Labs (MYL)
  • Novo Nordisk (NVO)
  • Robert Half (RHI)

Lob dash 20130412

Mylan Labs (MYL)

Myl 10yr 20130412

Novo Nordisk (NVO)

Love the company … would probably want to wait for a slightly higher PAR and a clear reversal in the RSI trend.

Nvo 10yr 20130412

Robert Half (RHI)

This community favorite has had a heckuva run over the last several months. With a PAR (5.9%) less than the market average (MIPAR = 7.0%) and relatively rare RSI breaks and excursions over the last ten years, if you’re holding this high-quality (Quality Rank = 88th percentile) career and employment leader, your recent gains may be worth capturing/protecting.

Check overall portfolio return forecasts and this RSI break condition could be a tiebreaker when pondering selling candidates.

Rhi 10yr 20130412

Value Line Low Total Return Screen (4/12/2013)

Photo Credit: bayat via Compfight cc

Companies of Interest

This week’s short list is the type of list we start to see near market tops. Several of the companies fail to reach the top quality quintile (Quality Ranking > 80) and we included AFLAC (AFL) although it’s on the edge.

We’ll be spending more time this month with Teva Pharma (TEVA) and the generic pharma industry to examine the bigger picture and longer term expectations. It will be part of the agenda for the Round Table on April 30.

We’ll also take a look at Robert Half (RHI) as a study candidate — but from the perspective of “traps” as community favorite RHI ends up in the “Look Out Below” roster this week along with Mylan Labs (MYL) and Novo Nordisk (NVO).

Materially Stronger: Biogen Idec (BIIB), Bristol-Myers Squibb (BMY), Kelly Services (KELYA), Albany Molecular (AMRI), BRE Properties (BRE), Public Storage (PSA), Investors Banc (ISBC)

Materially Weaker: Alcoa (AA), Anglogold Ashanti (AU), People’s United Financial (PBCT)

Market Barometers

The median Value Line low total return forecast is 6.7%, compared to 6.7% last week.